There is a surgical option to treat CSR, but what is a potential downside?

There is a surgical option to treat CSR, but what is a potential downside?

• A. No downsides
• B. It can lead to other complications down the line
• C. It always cures CSR
• D. It causes immediate CNV in all patients

Answer: (B)

When treating CSR with a surgical option, the idea to focus on is that the intervention may address the current issue but can bring new risks that show up later. Intraocular surgery carries a range of potential complications—such as cataract progression in phakic eyes, infection inside the eye, pressure changes, inflammatory responses, or iatrogenic retinal tears or detachments—that could affect vision even after an initial improvement. Because of these possible downstream issues, a downside of the surgical approach is that it can lead to other complications down the line. The other statements aren’t accurate: there isn’t no downside, it doesn’t always cure CSR, and it doesn’t cause immediate choroidal neovascularization in all patients.

When treating CSR with a surgical option, the idea to focus on is that the intervention may address the current issue but can bring new risks that show up later. Intraocular surgery carries a range of potential complications—such as cataract progression in phakic eyes, infection inside the eye, pressure changes, inflammatory responses, or iatrogenic retinal tears or detachments—that could affect vision even after an initial improvement. Because of these possible downstream issues, a downside of the surgical approach is that it can lead to other complications down the line. The other statements aren’t accurate: there isn’t no downside, it doesn’t always cure CSR, and it doesn’t cause immediate choroidal neovascularization in all patients.